Devi Kasinathan News Today

Innovative study on mice leads to a potential targeted monoclonal antibody therapy to manage Type I diabetes. Study highlights need for human version of antibody.

A new type 1 diabetes drug hides insulin-making beta cells from the immune system and shields them from attack, a study with mice shows.

Scientists at Johns Hopkins Medicine say that an experimental monoclonal antibody drug called mAb43 appears to prevent and reverse the onset of clinical type 1

Scientists at Johns Hopkins Medicine say that an experimental monoclonal antibody drug called mAb43 appears to prevent and reverse the onset of clinical type 1